AAAAAA
Results:
1-21
|
Results: 21
Authors:
DANERINAVARRO A
MACIASLOPEZ G
OCEGUERAVILLANUEVA A
DELTOROARREOLA S
BRAVOCUELLAR A
PEREZMONTFORT R
ORBACHARBOUYS S
Citation: A. Danerinavarro et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITORS (PAI-1 AND PAI-2) IN EXTRACTS OF INVASIVE CERVICAL-CARCINOMA AND PRECURSOR LESIONS, European journal of cancer, 34(4), 1998, pp. 566-569
Authors:
BONHOMMEFAIVRE L
MACE A
BEZIE Y
MARION S
BINDOULA G
SZEKELY AM
FRENOIS N
AUCLAIR H
ORBACHARBOUYS S
BIZI E
Citation: L. Bonhommefaivre et al., ALTERATIONS OF BIOLOGICAL PARAMETERS IN MICE CHRONICALLY EXPOSED TO LOW-FREQUENCY (50 HZ) ELECTROMAGNETIC-FIELDS, Life sciences, 62(14), 1998, pp. 1271-1280
Authors:
BRAVOCUELLAR A
ASTENGOOSUNA C
DANERINAVARRO A
HERNANDEZFLORES G
GOMEZCONTRERAS PC
RAMOSZEPEDA R
ORBACHARBOUYS S
Citation: A. Bravocuellar et al., ENHANCED FUNCTIONAL-CAPACITY OF THE PERITONEAL-MACROPHAGES AS ANTIGEN-PRESENTING CELLS AFTER ACLACINOMYCIN TREATMENT IN MICE, Biomedicine & pharmacotherapy, 51(4), 1997, pp. 181-184
Authors:
BONHOMMEFAIVRE L
MATHIEU MC
GROSSIORD JL
DEPREATERE P
COUARRAZE G
ORBACHARBOUYS S
PUISIEUX F
SEILLER M
Citation: L. Bonhommefaivre et al., FORMULATION OF A CHARCOAL SUSPENSION FOR INTRATUMOR INJECTION .1. STUDY OF THE NATURE, GRANULOMETRY, AND CONCENTRATION, Pharmaceutical research, 14(2), 1997, pp. 218-223
Authors:
MATHE G
PONTIGGIA P
ORBACHARBOUYS S
TRIANA K
AMBETIMA N
MORETTE C
HALLARD M
BLANQUET D
Citation: G. Mathe et al., AIDS THERAPY WITH 2, 3 OR 4 AGENT COMBINATIONS, APPLIED IN SHORT SEQUENCES, DIFFERING FROM EACH OTHER BY DRUG ROTATION .1. FIRST OF 2 PARTS- A PHASE-I TRIAL EQUIVALENT, CONCERNING 5 VIROSTATICS - AZT, DDI, DDC, ACRIFLAVINE AND AN ELLIPTICINE ANALOG, Biomedicine & pharmacotherapy, 50(5), 1996, pp. 220-227
Authors:
BONHOMMEFAIVRE L
SEILLER M
BIZI E
DEPREATERE P
GROSSIORD JL
FREDJ G
ORBACHARBOUYS S
Citation: L. Bonhommefaivre et al., INFLUENCE OF EXCIPIENTS ON MACROPHAGE ACTIVATION AND MOBILIZATION, STP pharma sciences, 5(6), 1995, pp. 447-451
Authors:
BONHOMMEFAIVRE L
BIZI E
MARION S
BEZIE Y
RUDANT E
AUCLAIR H
ORBACHARBOUYS S
Citation: L. Bonhommefaivre et al., EFFECTS OF SUBCHRONIC 50-HZ 5-MU-T MAGNETIC-FIELD EXPOSURE ON HEMATOLOGICAL PARAMETERS IN MICE, Electro- and magnetobiology, 14(3), 1995, pp. 193-197
Authors:
BONHOMME L
BIZI E
MARION S
BEZIE Y
RUDANT E
AUCLAIR H
ORBACHARBOUYS S
Citation: L. Bonhomme et al., HEMATOLOGY OF MICE EXPOSED TO ENVIRONMENTAL 50-HZ 5-MU-T MAGNETIC-FIELDS, The FASEB journal, 9(4), 1995, pp. 959-959
Authors:
BRAVOCUELLAR A
PEREZMEDINA R
OROZCOVELASCO F
ASTENGOOSUNA C
ORBACHARBOUYS S
Citation: A. Bravocuellar et al., ERYTHROCYTE SUPEROXIDE-DISMUTASE ACTIVITY DURING NORMAL OR HIGH-RISK PREGNANCY, AND IN PREMATURE AND NORMAL TERM INFANTS, La Presse medicale, 24(29), 1995, pp. 1360-1360
Authors:
MATHE G
ORBACHARBOUYS S
BIZI E
COURT B
Citation: G. Mathe et al., THE SO-CALLED PHYTO-ESTROGENIC ACTION OF PYGEUM-AFRICANUM EXTRACT, Biomedicine & pharmacotherapy, 49(7-8), 1995, pp. 339-340
Authors:
DANERINAVARRO A
DELTOROARREOLA S
BRAVOCUELLAR A
CABRERA N
ORBACHARBOUYS S
PEREZMONTFORT R
Citation: A. Danerinavarro et al., PROTEOLYTIC ACTIVITY IN EXTRACTS OF INVASIVE CERVICAL-CARCINOMA AND PRECURSOR LESIONS, Biomedicine & pharmacotherapy, 49(6), 1995, pp. 304-310
Authors:
DANERINAVARRO A
DELTOROARREOLA A
GARCIAVELAZCO JC
DELTOROARREOLA S
ORBACHARBOUYS S
BRAVOCUELLAR A
Citation: A. Danerinavarro et al., L-5178-Y LYMPHOMA ASSOCIATED IMMUNOSUPPRESSION IN BALB C MICE/, Biomedicine & pharmacotherapy, 49(1), 1995, pp. 39-44
Authors:
BONHOMME L
BIZI E
MARION S
AUCLAIR H
PHAM YT
BOTTIUS L
FREDI G
ORBACHARBOUYS S
Citation: L. Bonhomme et al., PERIPHERAL-BLOOD CELL CHANGES OF YOUNG MICE LIVING IN AN ENVIRONMENTAL LOW-FREQUENCY ELECTROMAGNETIC-FIELD (ELF), The FASEB journal, 8(4), 1994, pp. 10000399-10000399
Authors:
MATHE G
PONTIGGIA P
BOURUT C
CHENU E
ORBACHARBOUYS S
Citation: G. Mathe et al., IN-VIVO ERADICATION OF FRIEND-VIRUS AS AN EXPERIMENTAL HIV-MODEL, BY COMBINATION OF ZIDOVUDINE, ACRIFLAVINE AND AN ELLIPTICINE ANALOG - POSSIBLE APPLICATION TO THE TREATMENT OF HUMAN PRE-AIDS, Biomedicine & pharmacotherapy, 48(2), 1994, pp. 51-53
Authors:
MATHE G
MORETTE C
HALLARD M
SALA M
ORBACHARBOUYS S
Citation: G. Mathe et al., CHANGES IN THE LEVEL OF BLOOD SUPPRESSOR CD8-1 P24 ANTIGEN REAPPEARS IN THE BLOOD(C57+ LYMPHOCYTES, WHEN HIV), Biomedicine & pharmacotherapy, 48(1), 1994, pp. 3-5
Authors:
BRAVOCUELLAR A
NOWACKI W
HILLOVA J
HILL M
ORBACHARBOUYS S
Citation: A. Bravocuellar et al., IN-VITRO INHIBITION OF TUMOR-CELL GROWTH BY CON-A SPLEEN-CELL SUPERNATANT AND RECOMBINANT IL-2, Journal of experimental & clinical cancer research, 13(4), 1994, pp. 349-353
Authors:
ORBACHARBOUYS S
HILLOVA J
Citation: S. Orbacharbouys et J. Hillova, CANCER-IMMUNOTHERAPY - YESTERDAY AND TOMORROW, International journal of immunopharmacology, 16(5-6), 1994, pp. 381-383
Authors:
OCENASKOVA J
MARA M
ORBACHARBOUYS S
LECLERC M
BAROTCIORBARU R
Citation: J. Ocenaskova et al., DEPRESSION OF CYTOCHROME-P-450 IN MOUSE-LIVER INDUCED BY FRACTIONS FROM NOCARDIA-OPACA, International journal of immunopharmacology, 16(11), 1994, pp. 951-955
Authors:
MATHE G
CHENU E
BOURUT C
ORBACHARBOUYS S
Citation: G. Mathe et al., THE IN-VIVO EFFECT OF ELLIPTICINE ANALOGS ON THE BLOOD-CONCENTRATION OF FRIEND-VIRUS - A MURINE MODEL FOR STUDYING ANTI-HIV DRUGS, Biomedicine & pharmacotherapy, 47(10), 1993, pp. 457-460
Authors:
BONHOMME L
BIZI E
ORBACHARBOUYS S
BENOIST JF
FREDJ G
Citation: L. Bonhomme et al., MACROPHAGE ACTIVITY MAY BE MODIFIED IN-VIVO BY GALENICAL EXCIPIENTS, International journal of pharmaceutics, 96(1-3), 1993, pp. 180000007-180000010
Authors:
MATHE G
ITZHAKI M
ORBACHARBOUYS S
Citation: G. Mathe et al., BESTATIN SPECIFICALLY ENHANCES THE NUMBER OF CD4-CELLS IN PERIPHERAL-BLOOD IN PATIENTS WHOSE CD8+ T-CELL NUMBERS ARE ALSO DEPRESSED( T), International journal of immunotherapy, 9(3), 1993, pp. 165-167
Risultati:
1-21
|